Spironolactone: disposition, metabolism, pharmacodynamics, and bioavailability.
D000818:Animals; D001682:Biological Availability; D001711:Biotransformation; D002191:Canrenoic Acid / Q000378:metabolism; D004338:Drug Combinations; D004912:Erythrocytes / Q000378:metabolism; D005502:Food; D006207:Half-Life; D006801:Humans; D006852:Hydrochlorothiazide / Q000378:metabolism; D007700:Kinetics; D008895:Milk, Human / Q000378:metabolism; D011485:Protein Binding; D013045:Species Specificity; D013148:Spironolactone / Q000008:administration & dosage / Q000378:metabolism*; D014018:Tissue Distribution
D004338:Drug Combinations; D006852:Hydrochlorothiazide; D013148:Spironolactone; D002191:Canrenoic Acid